news Hydra Biosciences and Boehringer Ingelheim collaborate to research treatments for renal diseases and disorders 14 April 2015 | By Victoria White Hydra Biosciences and Boehringer Ingelheim have entered into a research collaboration with a primary focus on the treatment of renal diseases and disorders...
news Hydra Biosciences and Boehringer Ingelheim announce worldwide collaboration to develop small-molecule inhibitors for the treatment of central nervous system diseases and disorders 24 April 2014 | By Boehringer Ingelheim Hydra Biosciences, Inc. and Boehringer Ingelheim jointly announced that they have entered into a worldwide collaboration to research and develop small-molecule TRPC4/5 inhibitors...